DIAGNOSIS AND MANAGEMENT OF CIRRHOSIS AND ITS COMPLICATIONS

Abstract

Background:

Cirrhosis represents the advanced stage of chronic liver disease and is characterized by progressive fibrosis, nodular regeneration, and distortion of hepatic architecture. Alcohol use, chronic viral hepatitis, and nonalcoholic fatty liver disease remain major etiologic drivers, while portal hypertension, ascites, hepatic encephalopathy, variceal hemorrhage, and hepatocellular carcinoma account for much of the disease burden.

Objective:

To review current noninvasive diagnostic modalities and summarize evidence-based strategies for the management of cirrhosis and its major complications.

Methodology:

This narrative review synthesized recent clinical studies, practice guidelines, and expert reviews on cirrhosis diagnosis and treatment. Electronic searches were performed in PubMed, Scopus, ScienceDirect, and Google Scholar. English-language articles focused on noninvasive diagnosis, complications, treatment, follow-up, and prognosis were prioritized, with approximately 40 to 50 relevant studies and guidelines included.

Results:

The reviewed evidence supports a stepwise noninvasive approach to fibrosis staging and cirrhosis detection. FIB-4 values below 1.3 help exclude advanced fibrosis, transient elastography below 8 kPa helps rule out cirrhosis, and sequential use of APRI and FIB-4 improves diagnostic sensitivity. Among therapeutic strategies, nonselective beta-blockers reduce first decompensation in compensated cirrhosis with clinically significant portal hypertension; sodium restriction, diuretics, albumin-supported paracentesis, and TIPS remain central for ascites control; lactulose and rifaximin remain important in hepatic encephalopathy management.

Conclusion:

Early deployment of noninvasive diagnostic tools together with prompt guideline-based management is essential to improve survival and quality of life in patients with cirrhosis. Multidisciplinary care that integrates risk stratification, complication prevention, and timely escalation to interventional therapies offers the strongest opportunity for better outcomes.